In trading on Monday, shares of the iShares MSCI Malaysia ETF (EWM - Get Report) entered into oversold territory, changing hands as low as $8.05 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator used to measure momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.In the case of iShares MSCI Malaysia, the RSI reading has hit 29.1 — by comparison, the RSI reading for the S&P 500 is currently 47.6. A bullish investor could look at EWM's 29.1 reading as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. Looking at a chart of one year performance (below), EWM's low point in its 52 week range is $7.11 per share, with $13.80 as the 52 week high point — that compares with a last trade of $8.05. iShares MSCI Malaysia shares are currently trading down about 2.1% on the day.
More from Stocks
Dow Futures Slide, Global Stocks Slump on Renewed U.S.-China Trade Doubts
Wall Street futures indicated a weaker open Wednesday, following selloffs in European and Asia markets, after China condemned a U.S. Senate on human rights in Hong Kong and President Donald Trump again threatened to increase tariffs if the two sides aren't able to negotiate a near-term trade agreement.
Alibaba Prices $12.9 Billion Hong Kong Share Sale in Biggest IPO of 2019
Alibaba priced its secondary offering on the Hong Kong Stock Exchange Wednesday, capping what is likely to be the biggest IPO of the year.
Deutsche Bank, European Rivals Slide After ECB Report Cautions on Profits, Risks
Deutsche Bank shares led rivals lower Wednesday after the European Central Bank warned that low interest rates could lead to excessive risk taking that could threaten the single currency area's financial stability and noted deteriorating earnings prospects for regional lenders.
Shares of CRISPR Therapeutics Fall in After Hours Trading on Share Offering
Stock had risen shaply during regular session on gene therapy progress.